newsfilter
← Latest News
Business Wire·

Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress

Productive meeting held with the FDA; planning for tabelecleucel BLA resubmission Operating efficiencies and ATM proceeds extend cash runway into mid-2027 Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in